Method of treating diabetic complications i.e. peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies with cGMP PDE5 inhibitors such as sildenafil

摘要

A cGMP PDE5 inhibitor can be used in the manufacture of a medicament fro the treatment of autonomic neuropathies, CREST syndrome, erythromatosis, rheumatoid diseases, onychiomycosis, Raynaud's Phenomenon and peripheral neuropathies. Preferably the inhibitor is sildenafil.